cannabis indica

Náusea e Vômito por Quimioterapia

termo de indexação original: Chemotherapy-induced Nausea & Vomiting

O acervo do Cannabis Indica reúne 101 estudos científicos que tocam a condição Náusea e Vômito por Quimioterapia, publicados entre 1975 e 2023. Pela leitura automatizada, 83 (82%) foram classificados como favoráveis, 9 (9%) como inconclusivos e 9 (9%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (41 estudos), seguido de ensaio clínico duplo-cego (28). Os compostos mais presentes são THC Farmacêutico, Tetraidrocanabinol (THC) e THC:CBD Farmacêutico. Aparece com frequência ao lado de Náusea e Vômito, Dor e Câncer.

Estudos indexados
101
Período coberto
1975–2023
Favoráveis
83 · 82%
Inconclusivos
9 · 9%
Desfavoráveis
9 · 9%
Termo original
Chemotherapy-induced Nausea & Vomiting

O acervo em números

Tipo de estudo

Metanálise41
Ensaio Clínico Duplo-Cego28
Estudo em Animais14
Metanálise Clínica8
Ensaio Clínico7
Estudo Laboratorial3

Direção do resultado

Favorável83
Inconclusivo9
Desfavorável9

Por década

1970s2
1980s18
1990s4
2000s11
2010s28
2020s38

101 estudos

Filtrar e buscar no acervo →
  1. 2023

    Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids

    FavorávelEstudo LaboratorialDorCâncerInflamaçãoTetraidrocanabinol (THC)THC Farmacêutico+25
  2. 2023

    Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm - A Randomized Pilot Study

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerDor — CrônicaTHC FarmacêuticoTHC:CBD Farmacêutico+8
  3. 2023

    Cannabinoids for symptom management in children with cancer: It's complicated

    InconclusivoMetanáliseDorCâncerDor — Oncológica
  4. 2023

    Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis

    InconclusivoMetanálise ClínicaDorDependência QuímicaCâncer+15
  5. 2023

    Cannabis-Induced Acute Encephalopathy in a 94-Year-Old Woman Due to Family Administration of Cannabidiol (CBD) Products: A Case Report

  6. 2023

    Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma

  7. 2023

    Could cannabinoids provide a new hope for ovarian cancer patients?

  8. 2023

    Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends

    FavorávelMetanáliseDorCâncerDor — CrônicaTHC FarmacêuticoCBD Farmacêutico+16
  9. 2023

    Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial

    FavorávelEnsaio Clínico Duplo-CegoCâncerNáusea e VômitoCâncer — Ovário+2
  10. 2023

    Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection

    InconclusivoMetanálise ClínicaDorCâncerAnsiedadeTHC FarmacêuticoTHC:CBD Farmacêutico+9
  11. 2022

    A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong

  12. 2022

    C-phycocyanin alleviated cisplatin-induced oxidative stress and inflammation via gut microbiota—metabolites axis in mice

    FavorávelEstudo em AnimaisDorInflamaçãoDoenças Cardiovasculares (DCV)Ficocianina+5
  13. 2022

    Cannabidiol Interferes with Establishment of Δ 9-Tetrahydrocannabinol-Induced Nausea Through a 5-HT 1A Mechanism

  14. 2022

    Cannabinoids orchestrate cross-talk between cancer cells and endothelial cells in colorectal cancer

    DesfavorávelEstudo em AnimaisCâncerCâncer — CólonCâncer — Metastático
  15. 2022

    Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences

  16. 2022

    Controversial Link between Cannabis and Anticancer Treatments—Where Are We and Where Are We Going? A Systematic Review of the Literature

    FavorávelMetanáliseDorCâncerAnsiedadeTetraidrocanabinol (THC)THC Farmacêutico+17
  17. 2022

    Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?

  18. 2022

    Evaluation of Sex Differences in the Potential of Δ9-Tetrahydrocannabinol, Cannabidiol, Cannabidiolic Acid, and Oleoyl Alanine to Reduce Nausea-Induced Conditioned Gaping Reactions in Sprague-Dawley Rats

  19. 2022

    Herbal Approaches to Pediatric Functional Abdominal Pain

    InconclusivoMetanáliseDorInflamaçãoDor — CrônicaTHC Farmacêutico+10
  20. 2022

    In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center

    FavorávelMetanáliseDorCâncerAnsiedade+14
  21. 2022

    Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review

  22. 2022

    Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer

  23. 2022

    Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know

  24. 2022

    Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition

    DesfavorávelMetanáliseDorDependência QuímicaCâncerTetraidrocanabinol (THC)+12
  25. 2022

    The Effectiveness of Common Cannabis Products for Treatment of Nausea

    FavorávelMetanáliseNáusea e VômitoEnjoo Matinal na GestaçãoCinetose
  26. 2022

    The Medicinal Natural Products of Cannabis sativa Linn.: A Review

  27. 2022

    Therapeutic Effects of Medicinal Cannabinoids on the Gastrointestinal System in Pediatric Patients: A Systematic Review

    FavorávelMetanáliseDII — Doença Inflamatória Intestinal
  28. 2021

    Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?

    FavorávelMetanáliseDorCâncerInflamaçãoCBD Farmacêutico+5
  29. 2021

    Cannabis consumption in young adults with cancer: descriptive study

    FavorávelMetanáliseDorCâncerAnsiedade+3
  30. 2021

    Mixed methods study of the potential therapeutic benefits from medical cannabis for patients in Florida

    FavorávelMetanáliseDorDor — CrônicaDepressão+6
  31. 2021

    Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions

  32. 2021

    Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting

  33. 2020

    Capsaicin Is a Negative Allosteric Modulator of the 5-HT3 Receptor

    FavorávelEstudo LaboratorialDorAnsiedadeDepressãoCapsaicina (CAPS)+2
  34. 2020

    Effect of combined doses of Δ 9-tetrahydrocannabinol and cannabidiol or tetrahydrocannabinolic acid and cannabidiolic acid on acute nausea in male Sprague-Dawley rats

  35. 2020

    Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews

  36. 2020

    Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

    FavorávelEnsaio Clínico Duplo-CegoCâncerNáusea e VômitoTHC:CBD Farmacêutico
  37. 2020

    Small bowel intussusception in marijuana users

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Crônica+6
  38. 2020

    The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects—A Randomized Clinical Trial

  39. 2019

    Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting

    FavorávelMetanáliseNáusea e Vômito
  40. 2019

    Chemotherapy‐induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol

  41. 2018

    Patient Counseling Guidelines for the Use of Cannabis for the Treatment of Chemotherapy-Induced Nausea/Vomiting and Chronic Pain

    FavorávelMetanáliseDorDor — CrônicaNáusea e Vômito+1
  42. 2018

    Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review

    DesfavorávelMetanáliseCâncerNáusea e VômitoTHC Farmacêutico
  43. 2018

    Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms.

    FavorávelMetanáliseDorDor — CrônicaEsclerose Múltipla+2
  44. 2018

    The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial

    FavorávelEnsaio Clínico Duplo-CegoDorInsônia e Distúrbios do SonoAnorexia (perda de apetite)THC Farmacêutico+4
  45. 2017

    A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery

  46. 2017

    Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5‐HT1A receptor‐mediated suppression of nausea and anxiety in rats

  47. 2016

    Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.

    FavorávelMetanáliseNáusea e Vômito
  48. 2016

    Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting.

    FavorávelMetanáliseNáusea e VômitoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+11
  49. 2016

    Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics

  50. 2016

    Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.

    FavorávelMetanáliseNáusea e VômitoTHC FarmacêuticoTHC:CBD Farmacêutico
  51. 2016

    Hypotension associated with ingestion of cannabinoids in two children with cancer.

    InconclusivoMetanáliseCâncerEfeitos Adversos da CannabisTetraidrocanabinol (THC)
  52. 2015

    A 4-week pilot study with the cannabinoid receptor agonist dronabinol and its effect on metabolic parameters in a randomized trial

    FavorávelEnsaio Clínico Duplo-CegoDorDoenças Cardiovasculares (DCV)Dor — AgudaTHC Farmacêutico+3
  53. 2015

    Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.

    FavorávelMetanáliseNáusea e Vômito
  54. 2015

    Endocannabinoid Mechanisms Influencing Nausea.

  55. 2015

    Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDorCâncerInsônia e Distúrbios do SonoTHC Farmacêutico+5
  56. 2015

    Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting.

    FavorávelMetanáliseNáusea e Vômito
  57. 2015

    Safety of oral dronabinol during opioid withdrawal in humans

  58. 2015

    Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.

    FavorávelMetanáliseDorCâncerDoenças Cardiovasculares (DCV)+9
  59. 2013

    Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation.

  60. 2013

    Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.

  61. 2012

    Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

  62. 2011

    Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics.

    FavorávelMetanáliseNáusea e VômitoTHC Farmacêutico
  63. 2011

    Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerInflamaçãoTHC Farmacêutico+9
  64. 2011

    Update and new trends in antiemetic therapy: the continuing need for novel therapies.

    FavorávelMetanáliseNáusea e Vômito
  65. 2010

    Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood

    FavorávelMetanálise ClínicaNáusea e Vômito
  66. 2010

    Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoTHC:CBD Farmacêutico
  67. 2009

    Efficacy of Crude Marijuana and Synthetic Delta-9-Tetrahydrocannabinol as Treatment for Chemotherapy-Induced Nausea and Vomiting: A Systematic Literature Review.

    FavorávelMetanáliseNáusea e VômitoTHC Farmacêutico
  68. 2009

    Nausea and vomiting in people with cancer and other chronic diseases

    DesfavorávelMetanálise ClínicaCâncerDII — Doença Inflamatória IntestinalHepatite
  69. 2008

    Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain

    FavorávelMetanálise ClínicaDorDor — OncológicaTHC Farmacêutico
  70. 2008

    Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis

    FavorávelMetanálise ClínicaTHC Farmacêutico
  71. 2007

    Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret

  72. 2007

    Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoTHC Farmacêutico
  73. 2006

    Comparison Of Orally Administered Cannabis Extract And Delta-9-tetrahydrocannabinol In Treating Patients With Cancer-related Anorexia-cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Clinical Trial From The Cannabis-In-Cachexia-Study-Group

    InconclusivoEnsaio Clínico Duplo-CegoCâncerAnorexia (perda de apetite)CaquexiaTetraidrocanabinol (THC)+1
  74. 2006

    The emerging role of cannabinoid neuromodulators in symptom management.

    FavorávelMetanálise ClínicaDorCâncerNáusea e VômitoTHC Farmacêutico+1
  75. 2003

    Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

  76. 2001

    Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.

    FavorávelMetanáliseNáusea e VômitoTetraidrocanabinol (THC)THC Farmacêutico+1
  77. 2001

    Hu 210: a potent tool for investigations of the cannabinoid system

    FavorávelMetanáliseDorInflamaçãoDor — CrônicaCanabinoides Sintéticos HU-x+3
  78. 1997

    Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol).

    FavorávelMetanáliseDorCâncerNáusea e VômitoTHC Farmacêutico+8
  79. 1995

    An efficient new cannabinoid antiemetic in pediatric oncology.

    FavorávelEnsaio ClínicoNáusea e VômitoDelta-8-THC
  80. 1991

    Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoTetraidrocanabinol (THC)THC Farmacêutico
  81. 1990

    Case report: the effect of tetrahydrocannabinol on food intake during chemotherapy

  82. 1989

    Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid

  83. 1988

    A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues

    FavorávelEnsaio ClínicoNáusea e VômitoTetraidrocanabinol (THC)THC Farmacêutico
  84. 1988

    Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy

    FavorávelEnsaio ClínicoNáusea e Vômito
  85. 1988

    Inhalation marijuana as an antiemetic for cancer chemotherapy

    FavorávelEnsaio ClínicoNáusea e Vômito
  86. 1987

    Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito
  87. 1986

    Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito
  88. 1986

    Nabilone: an alternative antiemetic for cancer chemotherapy

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoTHC Farmacêutico
  89. 1986

    Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoCanabinoide Sintético (não especificado)THC Farmacêutico
  90. 1985

    A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoTHC Farmacêutico
  91. 1985

    Antiemetic Efficacy of Levonantradol Compared to delta-9-tetrahydrocannabinol for Chemotherapy-Induced Nausea and Vomiting

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoCanabinoides Sintéticos CP-x
  92. 1985

    Phase 1 Trial of Levonantradol in Chemotherapy-Induced Emesis

    FavorávelEnsaio ClínicoNáusea e VômitoCanabinoides Sintéticos CP-x
  93. 1983

    A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoTHC Farmacêutico
  94. 1983

    A randomised multicentre single blind comparison of a cannabinoid anti-emetic (Levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoCanabinoides Sintéticos CP-x
  95. 1983

    Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito
  96. 1983

    Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoTHC Farmacêutico
  97. 1982

    A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoTetraidrocanabinol (THC)THC Farmacêutico
  98. 1982

    Cannabis and cancer chemotherapy. A comparison of oral delta-9-THC and prochlorperazine

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito
  99. 1981

    Antiemetic Effect of Δ9‐Tetrahydrocannabinol in Chemotherapy‐Associated Nausea and Emesis As Compared to Placebo and Compazine.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoTetraidrocanabinol (THC)
  100. 1979

    Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer Chemotherapy.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoTetraidrocanabinol (THC)
  101. 1975

    Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e Vômito

Continue por aqui

Perguntas frequentes

Quantos estudos sobre náusea e vômito por quimioterapia estão indexados no acervo?
São 101 estudos, publicados entre 1975 e 2023. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 41 · Ensaio Clínico Duplo-Cego: 28 · Estudo em Animais: 14 · Metanálise Clínica: 8 · Ensaio Clínico: 7 · Estudo Laboratorial: 3. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 83 favoráveis, 9 inconclusivos e 9 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Náusea e Vômito por Quimioterapia — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/nausea-e-vomito-por-quimioterapia/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Náusea e Vômito por Quimioterapia — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/nausea-e-vomito-por-quimioterapia/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.